Direxion Daily S&P Biotech Bull 3X ETF
LABU
30 hedge funds and large institutions have $29.1M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 7 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
171% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more funds holding
Funds holding: 18 → 30 (+12)
12% more capital invested
Capital invested by funds: $26M → $29.1M (+$3.09M)
0.01% less ownership
Funds ownership: 0.29% → 0.27% (-0.01%)
15% less call options, than puts
Call options by funds: $30.1M | Put options by funds: $35.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.27M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.8M |
| 3 |
Morgan Stanley
New York
|
+$4.2M |
| 4 |
VF
Virtu Financial
New York
|
+$3.98M |
| 5 |
OPPM
Opus Point Partners Management
New York
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
-$10.2M |
| 2 |
Wolverine Trading
Chicago,
Illinois
|
-$1.09M |
| 3 |
CT
CMT Trading
Chicago,
Illinois
|
-$270K |
| 4 |
MCM
Mainstay Capital Management
Grand Blanc,
Michigan
|
-$107K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$99K |
LABU Hedge Fund Activity: Q4 2018 in Review
30 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2018, worth a combined $29.1M — up 12% from $26M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new LABU positions and 7 closed out — a net gain of 12 holders — while 9 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $9.27M. The largest seller was Hellman Jordan Management Company, exiting entirely with an estimated $10.2M sold.
- 30 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2018, up from 18 in Q3 2018.
- Funds reported $29.1M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2018, up 12% quarter-over-quarter.
- 19 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2018 and 7 closed out, a net change of +12 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2018 was Susquehanna International Group, an estimated $9.27M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2018 was Hellman Jordan Management Company, an estimated $10.2M sold.
Based on aggregated 13F filings for Q4 2018.